Validation Data Gallery
Tested Applications
Recommended dilution
| Application | Dilution | 
|---|---|
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Product Information
60333-1-PBS targets TMEM106B in WB, IP, Indirect ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human | 
| Host / Isotype | Mouse / IgG1 | 
| Class | Monoclonal | 
| Type | Antibody | 
| Immunogen | CatNo: Ag21448 Product name: Recombinant human TMEM106B protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-46 aa of BC033901 Sequence: MGKSLSHLPLHSSKEDAYDGVTSENMRNGLVNSEVHNEDGRNGDVS相同性解析による交差性が予測される生物種 | 
| Full Name | transmembrane protein 106B | 
| Calculated molecular weight | 31 kDa | 
| Observed molecular weight | ~40 kDa | 
| GenBank accession number | BC033901 | 
| Gene Symbol | TMEM106B | 
| Gene ID (NCBI) | 54664 | 
| RRID | AB_2881442 | 
| Conjugate | Unconjugated | 
| Form | |
| Form | Liquid | 
| Purification Method | Protein G purification | 
| UNIPROT ID | Q9NUM4 | 
| Storage Buffer | PBS only{{ptg:BufferTemp}}7.3 | 
| Storage Conditions | Store at -80°C. | 
Background Information
TMEM106B is a genetic risk factor for frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP). Amyotrophic lateral sclerosis (ALS), like FTLD-TDP, is characterized by pathological TDP-43 inclusions. TMEM106B expression in the brain may be linked to mechanisms of disease in FTLD-TDP and risk alleles confer genetic susceptibility by increasing gene expression.





